肿瘤微环境
癌症研究
免疫系统
化学
巨噬细胞极化
巨噬细胞
腺癌
肿瘤细胞
肿瘤发生
肺
肺癌
细胞
磷酸化
免疫疗法
信号转导
发病机制
肿瘤进展
细胞信号
细胞生物学
癌症
免疫监视
细胞存活
医学
免疫学
作者
Mingchao Wang,Zhihong Song,Hao Yuan,Chang Liu,Wei Wang,Naixue Yang,Keyong Sun,Shanshan Zhang,Xianhan Qin,jingwei li,Chen Tian,Runda Xu,Yixin Huang,Shicheng Hu,Xin Nie,Zhixin Bie,Xinquan Liu,Yi Yao,Xin Lin,Chunhua Lin
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2025-11-17
标识
DOI:10.1158/0008-5472.can-24-4392
摘要
Abstract Cancer cells are able to evade immune surveillance by engendering an immunosuppressive “cold” tumor microenvironment (cTME). A better understanding of the mechanisms underlying the establishment of a cTME in the initial phases of tumor formation could help uncover improved immunotherapeutic strategies. To characterize the temporal dynamics of the formation of cTME, we generated single-cell RNA-sequencing data during the initiation phases of EGFR-driven lung adenocarcinoma (LUAD). Macrophages in the TME underwent a state transition from anti-tumor macrophages to pro-tumor macrophages, which orchestrated the formation of a cTME. Tumor cell-derived BMP2/4 induced the polarization of pro-tumor macrophages, and inhibiting the BMP2/4-ACVR1 axis with ACVR1 inhibitor converted the cTME into a “hot” TME (hTME), resulting in a potent suppression of tumor growth. Furthermore, EGFR-mutant LUAD patients exhibited similar cTME characteristics as observed in mice, and high expression of ACVR1 correlated with worse patient prognosis. Overall, in addition to elucidating the role of pro-tumor macrophages in cTME formation, this study pinpoints targeting ACVR1 as a therapeutic strategy for treating EGFR-mutant lung cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI